AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/169
HEAT-SHOCK-PROTEIN PEPTIDE COMPLEXES AS IMMUNOTHERAPY FOR HUMAN CANCER
Authors: PRZEPIORKA D SRIVASTAVA PK
Citation: D. Przepiorka et Pk. Srivastava, HEAT-SHOCK-PROTEIN PEPTIDE COMPLEXES AS IMMUNOTHERAPY FOR HUMAN CANCER, Molecular medicine today, 4(11), 1998, pp. 478-484
CHEMOTHERAPY IMMEDIATELY FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: RAHMAN Z KAVANAGH J CHAMPLIN R GILES R HANANIA E FU SQ ZU ZF MEHRA R HOLMES F KUDELKA A CLAXTON D VERSCHRAEGEN C GAJEWSKI J ANDREEFF M HEIMFELD S BERENSON R ELLERSON D CALVERT L MECHETNER E HOLZMAYER T DAYNE A HAMER J BACHIER C OSTROVE J PRZEPIORKA D BURTNESS B COTE R BAST R HORTOBAGYI G DEISSEROTH A
Citation: Z. Rahman et al., CHEMOTHERAPY IMMEDIATELY FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER, Clinical cancer research, 4(11), 1998, pp. 2717-2721
TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES
Authors: KHOURI IF KEATING M KORBLING M PRZEPIORKA D ANDERLINI P OBRIEN S GIRALT S IPPOLITI C VONWOLFF B GAJEWSKI J DONATO M CLAXTON D UENO N ANDERSSON B GEE A CHAMPLIN R
Citation: If. Khouri et al., TRANSPLANT-LITE - INDUCTION OF GRAFT-VERSUS-MALIGNANCY USING FLUDARABINE-BASED NONABLATIVE CHEMOTHERAPY AND ALLOGENEIC BLOOD PROGENITOR-CELL TRANSPLANTATION AS TREATMENT FOR LYMPHOID MALIGNANCIES, Journal of clinical oncology, 16(8), 1998, pp. 2817-2824
ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER
Authors: UENO NT RONDON G MIRZA NQ GEISLER DK ANDERLINI P GIRALT SA ANDERSSON BS CLAXTON DF GAJEWSKI JL KHOURI IF KORBLING M MEHRA RC PRZEPIORKA D RAHMAN Z SAMUELS BI VANBESIEN K HORTOBAGYI GN CHAMPLIN RE
Citation: Nt. Ueno et al., ALLOGENEIC PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FOR POOR-RISK PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(3), 1998, pp. 986-993
ALLOGENEIC MARROW TRANSPLANTATION FOR MYELOPROLIFERATIVE DISORDERS OTHER THAN CHRONIC MYELOGENOUS LEUKEMIA - REVIEW OF 40 CASES
Authors: PRZEPIORKA D GIRALT S KHOURI I CHAMPLIN R BUESORAMOS C
Citation: D. Przepiorka et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MYELOPROLIFERATIVE DISORDERS OTHER THAN CHRONIC MYELOGENOUS LEUKEMIA - REVIEW OF 40 CASES, American journal of hematology, 57(1), 1998, pp. 24-28
MULTIDIMENSIONAL FLOW-CYTOMETRIC ANALYSIS OF DENDRITIC CELLS IN PERIPHERAL-BLOOD OF NORMAL DONORS AND CANCER-PATIENTS
Authors: SAVARY CA GRAZZIUTTI ML MELICHAR B PRZEPIORKA D FREEDMAN RS COWART RE COHEN DM ANAISSIE EJ WOODSIDE DG MCINTYRE BW PIERSON DL PELLIS NR REX JH
Citation: Ca. Savary et al., MULTIDIMENSIONAL FLOW-CYTOMETRIC ANALYSIS OF DENDRITIC CELLS IN PERIPHERAL-BLOOD OF NORMAL DONORS AND CANCER-PATIENTS, Cancer immunology and immunotherapy, 45(5), 1998, pp. 234-240
PHASE-II STUDY OF DACLIZUMAB FOR TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE
Authors: PRZEPIORKA D KERNAN N IPPOLITI C PAPADOPOULOS E GIRALT S KHOURI I LU J GAJEWSKI J DURETT A CLEARY R CHAMPLIN R ANDERSSON B LIGHT S
Citation: D. Przepiorka et al., PHASE-II STUDY OF DACLIZUMAB FOR TREATMENT OF ACUTE GRAFT-VS-HOST DISEASE, Experimental hematology, 26(8), 1998, pp. 35-35
PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC)
Authors: GAJEWSKI J RONDON G MIRZA N MEHRA R DONATO M ANDERLINI P KORBLING M THERIALT R KHOURI I GIRALT S BUZDAR A UENO N PRZEPIORKA D ANDERSSON B DURRETT A SALIBA R BRUTON J RAHMAN Z IPPOLITI C HORTABAQYI G RABER M BAST R CHAMPLIN R
Citation: J. Gajewski et al., PRELIMINARY-RESULTS OF A RANDOMIZED TRIAL COMPARING INTENSIVE CHEMOTHERAPY WITH GROWTH-FACTOR (GF) OR PERIPHERAL-BLOOD PROGENITOR (PBPC) CELL MOBILIZATION TO GROWTH-FACTOR ALONE FOR HEMATOPOIETIC RESCUE AFTER HIGH-DOSE CHEMOTHERAPY (HDC), Experimental hematology, 26(8), 1998, pp. 371-371
TRANSFUSION SUPPORT USING FILTERED UNSCREENED BLOOD PRODUCTS FOR CYTOMEGALOVIRUS-NEGATIVE ALLOGENEIC MARROW TRANSPLANT RECIPIENTS
Authors: NARVIOS AB PRZEPIORKA D TARRAND J CHAN KW CHAMPLIN R LICHTIGER B
Citation: Ab. Narvios et al., TRANSFUSION SUPPORT USING FILTERED UNSCREENED BLOOD PRODUCTS FOR CYTOMEGALOVIRUS-NEGATIVE ALLOGENEIC MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 22(6), 1998, pp. 575-577
THE USE OF TOPICAL CYCLOSPORINE-A IN OCULAR GRAFT-VERSUS-HOST-DISEASE
Authors: KIANG E TESAVIBUL N YEE R KELLAWAY J PRZEPIORKA D
Citation: E. Kiang et al., THE USE OF TOPICAL CYCLOSPORINE-A IN OCULAR GRAFT-VERSUS-HOST-DISEASE, Bone marrow transplantation, 22(2), 1998, pp. 147-151
ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION - A REPLACEMENT FOR BONE-MARROW TRANSPLANTATION
Authors: KORBLING M PRZEPIORKA D ANDERLINI P CHAMPLIN R
Citation: M. Korbling et al., ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION - A REPLACEMENT FOR BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 19-19
IMPACT OF PROPHYLAXIS REGIMEN ON THE INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION
Authors: PRZEPIORKA D IPPOLITI C KHOURI I ANDERLINI P FOLLODER J UENO N MEHRA R GIRALT S GAJEWSKI J CLEARY K CLAXTON D CHAMPLIN R ANDERSSON B KORBLING M
Citation: D. Przepiorka et al., IMPACT OF PROPHYLAXIS REGIMEN ON THE INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 26-26
BLOOD STEM-CELL PROCUREMENT - DONOR SAFETY ISSUES
Authors: ANDERLINI P PRZEPIORKA D KORBLING M CHAMPLIN R
Citation: P. Anderlini et al., BLOOD STEM-CELL PROCUREMENT - DONOR SAFETY ISSUES, Bone marrow transplantation, 21, 1998, pp. 35-39
ALLOGENEIC STEM-CELL TRANSPLANTATION FOR ADVANCED HODGKINS-DISEASE - THE ANDERSON,M.D. EXPERIENCE
Authors: ANDERLINI P ANDERSSON B GAJEWSKI J GIRALT S MEHRA R CLAXTON D UENO N KHOURI I PRZEPIORKA D DONATO M KORBLING M CHAMPLIN R
Citation: P. Anderlini et al., ALLOGENEIC STEM-CELL TRANSPLANTATION FOR ADVANCED HODGKINS-DISEASE - THE ANDERSON,M.D. EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 575-575
PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA
Authors: KHOURI IF ROMAGUERA J PALMER JL PUGH WC KORBLING M SAMUELS B GIRALT S RODRIGUEZ A PRZEPIORKA D MCLAUGHLIN P ANDERSSON B CLAXTON D MIRZA N MEHRA R HAGEMEISTER F CABANILLAS F CHAMPLIN R
Citation: If. Khouri et al., PRELIMINARY-REPORT OF A NEW ACTIVE REGIMEN FOR AGGRESSIVE MANTLE CELLLYMPHOMA, British Journal of Haematology, 102(1), 1998, pp. 240-241
PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION
Authors: RATANATHARATHORN V NASH RA PRZEPIORKA D DEVINE SM KLEIN JL WEISDORF D FAY JW NADEMANEE A ANTIN JH CHRISTIANSEN NP VANDERJAGT R HERZIG RH LITZOW MR WOLFF SN LONGO WL PETERSEN FB KARANES C AVALOS B STORB R BUELL DN MAHER RM FITZSIMMONS WE WINGARD JR
Citation: V. Ratanatharathorn et al., PHASE-III STUDY COMPARING METHOTREXATE AND TACROLIMUS (PROGRAF, FK506) WITH METHOTREXATE AND CYCLOSPORINE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS AFTER HLA-IDENTICAL SIBLING BONE-MARROW TRANSPLANTATION, Blood, 92(7), 1998, pp. 2303-2314
A PHASE-II STUDY OF BTI-322, A MONOCLONAL ANTI-CD2 ANTIBODY, FOR TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE
Authors: PRZEPIORKA D PHILLIPS GL RATANATHARATHORN V COTTLERFOX M SEHN LH ANTIN JH LEBHERZ D AWWAD M HOPE J MCCLAIN JB
Citation: D. Przepiorka et al., A PHASE-II STUDY OF BTI-322, A MONOCLONAL ANTI-CD2 ANTIBODY, FOR TREATMENT OF STEROID-RESISTANT ACUTE GRAFT-VERSUS-HOST DISEASE, Blood, 92(11), 1998, pp. 4066-4071
VARIABLE CHANGES IN LYMPHOCYTE SUBSET COMPOSITION (LSC) OCCUR DURING PRODUCTION OF HUMAN SUICIDAL LYMPHOCYTES - IMPLICATIONS FOR CLINICAL-TRIALS
Authors: MARINI FC SNELL V LU J PRZEPIORKA D KORNBLAU SM
Citation: Fc. Marini et al., VARIABLE CHANGES IN LYMPHOCYTE SUBSET COMPOSITION (LSC) OCCUR DURING PRODUCTION OF HUMAN SUICIDAL LYMPHOCYTES - IMPLICATIONS FOR CLINICAL-TRIALS, Cancer gene therapy, 4(6), 1997, pp. 86-86
PHASE-I TRIAL OF CYCLOSPORINE-INDUCED AUTOLOGOUS GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH MULTIPLE-MYELOMA UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE
Authors: GIRALT S WEBER D COLOME M DIMOPOULOS M MEHRA R VANBESIEN K GAJEWSKI J ANDERSSON B KHOURI I PRZEPIORKA D VONWOLFF B DELASALLE K KORBLING M SEONG D ALEXANIAN R CHAMPLIN R
Citation: S. Giralt et al., PHASE-I TRIAL OF CYCLOSPORINE-INDUCED AUTOLOGOUS GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH MULTIPLE-MYELOMA UNDERGOING HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL RESCUE, Journal of clinical oncology, 15(2), 1997, pp. 667-673
USE OF OCTREOTIDE IN THE SYMPTOMATIC MANAGEMENT OF DIARRHEA INDUCED BY GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
Authors: IPPOLITI C CHAMPLIN R BUGAZIA N PRZEPIORKA D NEUMANN J GIRALT S KHOURI I GAJEWSKI J
Citation: C. Ippoliti et al., USE OF OCTREOTIDE IN THE SYMPTOMATIC MANAGEMENT OF DIARRHEA INDUCED BY GRAFT-VERSUS-HOST DISEASE IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES, Journal of clinical oncology, 15(11), 1997, pp. 3350-3354
INDUCTION OF GRAFT-VERSUS-LEUKEMIA USING FLUDARABINE-BASED ALLOGENEICMINI-TRANSPLANTS AS TREATMENT FOR LYMPHOID MALIGNANCIES
Authors: KHOURI I KEATING M KORBLING M PRZEPIORKA D ANDERLINI P OBRIEN S VONWOLFF B GIRALT S GAJEWSKI J MEHRA R KANTARJIAN H CHAMPLIN R
Citation: I. Khouri et al., INDUCTION OF GRAFT-VERSUS-LEUKEMIA USING FLUDARABINE-BASED ALLOGENEICMINI-TRANSPLANTS AS TREATMENT FOR LYMPHOID MALIGNANCIES, Experimental hematology, 25(8), 1997, pp. 25-25
FOSCARNET FOR PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS UNABLE TO RECEIVE GANCICLOVIR
Authors: IPPOLITI C MORGAN A WARKENTIN D VANBESIEN K MEHRA R KHOURI I GIRALT S GAJEWSKI J CHAMPLIN R ANDERSSON B PRZEPIORKA D
Citation: C. Ippoliti et al., FOSCARNET FOR PREVENTION OF CYTOMEGALOVIRUS-INFECTION IN ALLOGENEIC MARROW TRANSPLANT RECIPIENTS UNABLE TO RECEIVE GANCICLOVIR, Bone marrow transplantation, 20(6), 1997, pp. 491-495
TOXICITIES OF TACROLIMUS AND CYCLOSPORINE-A AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION
Authors: WOO M PRZEPIORKA D IPPOLITI C WARKENTIN D KHOURI I FRITSCHE H KORBLING M
Citation: M. Woo et al., TOXICITIES OF TACROLIMUS AND CYCLOSPORINE-A AFTER ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION, Bone marrow transplantation, 20(12), 1997, pp. 1095-1098
SUCCESSFUL TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY WITH LOW-DOSE INTERLEUKIN-2
Authors: PRZEPIORKA D JAECKLE KA BIRDWELL RR FULLER GN KUMAR AJ HUH YO MCCUTCHEON I
Citation: D. Przepiorka et al., SUCCESSFUL TREATMENT OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY WITH LOW-DOSE INTERLEUKIN-2, Bone marrow transplantation, 20(11), 1997, pp. 983-987
LACK OF INTERACTION BETWEEN TACROLIMUS (FK506) AND METHOTREXATE IN BONE-MARROW TRANSPLANT RECIPIENTS
Authors: WINGARD JR NASH RA RATANATHARATHORN V FAY JW KLEIN JL PRZEPIORKA D MAHER RM DEVINE SM BOSWELL G BEKERSKY I FITZSIMMONS W
Citation: Jr. Wingard et al., LACK OF INTERACTION BETWEEN TACROLIMUS (FK506) AND METHOTREXATE IN BONE-MARROW TRANSPLANT RECIPIENTS, Bone marrow transplantation, 20(1), 1997, pp. 49-51
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>